Novel research shows that a reduced neural response to receiving rewards in teens predicts the first onset of depression, but not anxiety or suicidality. This is independent of pre-existing depressive or anxiety symptoms, ...
Dec 17, 2024
0
0
Almost three quarters of adolescents in Australia experience clinically significant depression or anxiety symptoms, with most being chronic, according to a new study. And preventive strategies outside our clinics are urgently ...
Dec 17, 2024
0
0
The decades-old anesthetic ketamine could be a game changer for treating severe depression, but there are still many questions about how the drug works, including exactly how it affects the brain's cells and circuits.
Dec 17, 2024
0
48
Can you literally step away from depression? A new global review of data found that "increasing the number of daily steps, even at modest levels, was associated with a reduction in depressive symptoms."
Dec 16, 2024
1
93
Dancing lowers the depression associated with Parkinson's disease, and the benefits can be seen in multiple ways, according to a study involving York University researchers published in the Journal of Medical Internet Research.
Dec 16, 2024
0
0
Subtle activation of a small subset of neurons in one region of the brain can make male mice resilient to, and even reverse, the detrimental effects of chronic stress. The same is true for female mice, but in a totally different ...
Dec 16, 2024
0
19
Prenatal exposure to selective serotonin reuptake inhibitors (SSRIs) is associated with an increased risk of functional constipation developing in offspring, according to a study published online Dec. 10 in Molecular Psychiatry.
Dec 13, 2024
0
0
Cognitive impairment, especially in learning and memory, is more likely among people with epilepsy, according to a study published online Nov. 19 in Epilepsia Open.
Dec 12, 2024
0
0
The Post Office scandal continues to have a "severe" impact on the mental health and lives of the loved ones of victims, new research shows.
Dec 12, 2024
0
0
Bionomics Limited is reporting that their experimental drug BNC210, a novel α7 nicotinic acetylcholine receptor modulator, significantly reduced symptom severity in patients with post-traumatic stress disorder (PTSD).
